8-K filings / November 16, 2026
REGENEREX PHARMA, INC.: A change of auditor
REGENEREX PHARMA, INC. filed a current report (Form 8-K) with the SEC on November 16, 2026. It reports a change of auditor.
Item 4.01
Change of auditor
-
New auditor
Rosenfield and Company PLLC
From the filing
Source
“On October 28, 2026, the Company’s Board of Directors finalized the approval of the appointment of Rosenfield and Company PLLC CPA of Corinth, Texas, as the Company’s independent registered public accounting firm, as per the engagement letter effective October 26, 2026.”
Read by code from this sentence of the filing. -
Engaged on
October 28, 2026
From the filing
Source
“On October 28, 2026, the Company’s Board of Directors finalized the approval of the appointment of Rosenfield and Company PLLC CPA of Corinth, Texas, as the Company’s independent registered public accounting firm, as per the engagement letter effective October 26, 2026.”
Read by code from this sentence of the filing.
Not investment advice.Read the filing on SEC.gov
Facts read from the filing's own text; a fact the filing does not state clearly is left out. All documents of this filing on SEC.gov.